《大行》大摩料药明生物(02269.HK)股价未来45日上升 目标价升至50元

阿斯达克财经
Feb 12

摩根士丹利发表技术研究报告,预期药明生物(02269.HK) 股价将于未来45日上升,发生此概率料介乎70%至80%。公司早前发盈喜,管理层在活动上指引2026财年增长加速,加上2025年整合项目数量增加16%,以及研究服务的强劲动能,均反映公司2026年的表现将强劲。同时,研究服务的势头将可带来与IP相关的收入,进一步提升盈利能力。公司近期亦与Vertex及再鼎医药(09688.HK) 达成对外...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10